Members of the Fine Gael parliamentary party met with Biogen, the biotechnology company which manufactures Skyclarys, a disease-modifying drug for Friedreich’s Ataxia, today. Fine Gael Parliamentary Party Chairperson, Deputy Micheál Carrigy, who has met with Biogen previously, met with representatives from the company again this afternoon, along with his colleagues Deputy Catherine Callaghan, Deputy Seán […] The post Fine Gael public representat…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.